PharmaBlock Sciences Nanjing Inc
SZSE:300725
PharmaBlock Sciences Nanjing Inc
SZSE:300725
Price:
35.74
CNY
4.93%
Market Cap:
¥8.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
PharmaBlock Sciences Nanjing Inc
SZSE:300725
|
CN |
|
Reckitt Benckiser Group PLC
LSE:RKT
|
UK |
|
E
|
enherent Corp
OTC:ENHT
|
US |
|
P
|
Penns Woods Bancorp Inc
NASDAQ:PWOD
|
US |
|
A
|
American Commerce Solutions Inc
OTC:AACS
|
US |
|
A
|
Al Mawarid Manpower Company SCJSC
SAU:1833
|
SA |
|
Spruce Power Holding Corp
NYSE:SPRU
|
US |
|
G
|
Guangzhou Holike Creative Home Co Ltd
SSE:603898
|
CN |
|
Tips Music Ltd
NSE:TIPSMUSIC
|
IN |
|
L E Lundbergforetagen AB (publ)
STO:LUND B
|
SE |
Multiples-Based Value
The Multiples-Based Value of one
PharmaBlock Sciences Nanjing Inc
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 35.74 CNY,
PharmaBlock Sciences Nanjing Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PharmaBlock Sciences Nanjing Inc Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
PharmaBlock Sciences Nanjing Inc Competitors
PharmaBlock Sciences Nanjing Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
PharmaBlock Sciences Nanjing Inc
SZSE:300725
|
8.4B CNY | 4.2 | 41.5 | 33.1 | 33.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD | 12.7 | 40.2 | 27.2 | 29 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD | 4.6 | 16.2 | 10 | 12.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF | 5.2 | 21.1 | 13 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP | 5.1 | 29.1 | 16.1 | 22.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 9.8 | 7.3 | 8.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD | 2.4 | 16.7 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
